WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics, today announced that Mark J. Ahn, Ph.D., President and Chief Executive Officer, will present a corporate overview at the BIO International Convention on Tuesday, June 28, 2011 at 10:30am EDT, at the Walter E. Washington Convention Center in Washington, DC.
